http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012512896-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 |
filingDate | 2009-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2012-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2012512896-A |
titleOfInvention | Sustained release pharmaceutical formulation |
abstract | The present invention comprises four main components: i) an effective amount of at least one drug substance; ii) at least one pharmaceutically acceptable water-swellable pH independent polymer; iii) at least one drug. An anionic pH-dependent polymer; and (iv) a) at least one pharmaceutically acceptable cationic polymer; and b) at least one pharmaceutically acceptable hydrocolloid. A matrix-type sustained release pharmaceutical preparation comprising a pharmaceutically acceptable polymer is provided. The formulation can be used with compounds having a wide range of solubility as well as compounds characterized by being hydrophobic or hydrophilic. [Selection] Figure 1 |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018514530-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10835497-B2 |
priorityDate | 2008-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2621.